首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >In situ-gelling gellan formulations as vehicles for oral drug delivery.
【24h】

In situ-gelling gellan formulations as vehicles for oral drug delivery.

机译:原位凝胶结冷胶制剂作为口服药物输送的载体。

获取原文
获取原文并翻译 | 示例
       

摘要

Gels formed in situ following oral administration of 1% (w/v) aqueous solutions of gellan to rats and rabbits were evaluated as sustained-release vehicles. The formulation contained calcium ions in complexed form, the release of which in the acidic environment of the stomach caused gelation of the gellan gum. The in vitro release of theophylline from the rigid gellan gels followed root-time kinetics over a period of 6 h. Plasma levels of theophylline after oral administration of gellan solutions and a commercial oral sustained-release liquid dosage form containing an identical drug concentration were compared in both rats and rabbits. Bioavailability of theophylline from gellan gels formed by in situ gelation in the animal stomach was increased by four-fivefold in rats and threefold in rabbits compared with that from the commercial oral formulation. There was no significant difference in the mean residence times of theophylline when administered by these two vehicles.
机译:将大鼠和兔子口服1%(w / v)吉兰糖水溶液后原位形成的凝胶评估为持续释放的载体。该制剂包含复合形式的钙离子,其在胃的酸性环境中释放导致结冷胶胶凝。茶碱从硬质吉兰糖凝胶中的体外释放遵循根时间动力学,历时6小时。在大鼠和兔子中,比较了口服吉兰糖溶液和含有相同药物浓度的市售口服缓释液剂型后茶碱的血浆水平。与市售口服制剂相比,通过在动物胃中原位凝胶化形成的吉兰糖凝胶的茶碱的生物利用度在大鼠中增加了四倍,在兔子中增加了三倍。当通过这两种媒介物给药时,茶碱的平均停留时间没有显着差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号